Newswire (Published: Tuesday, February 7, 2017, Received: Thursday, February 2, 2017, 4:21:30 PM CST)

Word Count: 355

Recent Findings from University of New England Provide New Insights into Prostate Cancer (Total depression and subtypes in prostate cancer survivors 10?years after treatment)

By a News Reporter-Staff News Editor at Cancer Weekly -- Research findings on Oncology - Prostate Cancer are discussed in a new report. According to news reporting originating in Armidale, Australia, by NewsRx journalists, research stated, "To describe the prevalence, severity and nature of depression in a sample of prostate cancer (PCa) survivors 10?years after diagnosis and treatment, 146 Australian patients from the RADAR trial who received their diagnosis 10?years previously completed the Zung Self-rating Depression Scale and a background questionnaire. Prevalence rates for clinically significant depression and severe depression were higher than those reported for the non-PCa men of the same age in Australia."

The news reporters obtained a quote from the research from the University of New England, "The most common subtype of depression was Anhedonia, followed by Cognitive depression. Change in eating habits was the most powerful depression symptom predicting Anhedonia."

According to the news reporters, the research concluded: "By providing the first detailed documentation of major depression prevalence in PCa survivors, plus describing the nature of that depression, these data suggest that there is an ongoing need to provide treatments for these men and that those treatments should be focussed upon loss of previously available sources of enjoyment."

For more information on this research see: Total depression and subtypes in prostate cancer survivors 10?years after treatment. European Journal of Cancer Care, 2016;():. (Wiley-Blackwell - www.wiley.com/; European Journal of Cancer Care - onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2354)

Our news correspondents report that additional information may be obtained by contacting C.F. Sharpley, Brain-Behaviour Research Group, University of New England, Armidale, NSW, Australia. Additional authors for this research include V. Bitsika, D.R. Christie, R. Bradford, A. Steigler and J.W Denham (see also Oncology - Prostate Cancer).

Keywords for this news article include: Armidale, Oncology, Epidemiology, Prostate Cancer, Prostatic Neoplasms, Australia and New Zealand.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC

Companies

University of New England

Places

Australia and New Zealand
Australia
Oceania

Subjects

Science and Technology
      Scientific Research
Health and Wellness
      Medical Conditions and Diseases
            Cancer
                  Prostate Cancer
            Men's Health Issues
                  Prostate Cancer